Skip to content

Depression: all studies

Page 124 of 1,034: studies 1,231 to 1,240 of 10,336, newest first. Back to the depression overview

Research

Personalized use of ketamine and esketamine for treatment-resistant depression.

Translational Psychiatry November 29, 2024 Gustavo C Medeiros, Isabella Demo, Fernando S Goes et al. 32 citations

A large and disproportionate portion of the burden associated with major depressive disorder (MDD) is due to treatment-resistant depression (TRD). Intravenous (R,S)-ketamine (ketamine) and intranasal (S)-ketamine (esketamine) are rapid-acting antidepressants that can effectively treat TRD. However, there is variability in response to ketamine/esketamine, and a personalized approach to their use...

DOI: 10.1038/s41398-024-03180-8 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Depression treatment Ketamine therapy Mental health breakthroughs +1

Exploring the Effects of Variety and Amount of Mindfulness Practices on Depression, Anxiety, and Stress Symptoms: Longitudinal Study on a Mental Health-Focused eHealth System for Patients With Breast or Prostate Cancer.

JMIR Mental Health November 21, 2024 Francesca Malandrone, Sara Urru, Paola Berchialla et al. 8 citations

Patients with cancer often face depression and anxiety, and mindfulness-based interventions, including internet-based versions, can effectively reduce these symptoms and improve their quality of life. This study aims to investigate the impact of internet-based mindfulness-based interventions (e-MBIs) on anxiety, depression, and stress symptoms in patients with prostate or breast cancer. The...

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder

Psychedelic Medicine November 18, 2024 Shakila Meshkat, Erica Kaczmarek, Zoe Doyle et al. 8 citations

Background: Bipolar II disorder (BD-II) is often associated with chronic and treatment resistant major depressive episodes. Psilocybin has shown promise for its rapid-acting antidepressant effects, though its impact on bipolar depression remains unexplored. In the present subgroup analysis of an already published trial on treatment-resistant depression (TRD), we aimed to preliminarily evaluate...

Combination of non-invasive brain stimulation with mindfulness-based interventions for anxiety and depression symptoms: systematic review and meta-analysis of randomized controlled trials.

European Archives of Psychiatry and Clinical Neuroscience November 17, 2024 Anastasia Demina, Benjamin Petit, Vincent Meille et al. 6 citations

In this article we aimed synthesize all available evidence regarding the effects of non-invasive brain stimulation (NIBS) techniques combined with mindfulness-based interventions (MBIs) on mental health indicators. We performed a systematic review of randomized controlled trials evaluating NIBS/MBIs combinations in clinical populations and a random effects pairwise meta-analysis of studies...

The effect and mechanism of low-dose esketamine in neuropathic pain-related depression-like behavior in rats.

Brain Research November 15, 2024 Lijuan Wang, Shuwu Zhao, Jiali Shao et al. 7 citations

Clinical evidence suggests that Esketamine (ESK) is an effective treatment for depression. However, the effects of Esketamine in treating depression-like behavior induced by neuropathic pain is unclear. The underlying molecular mechanisms require further investigation to provide new therapeutic targets for the treatment of clinical neuropathic pain-related depression. A neuropathic pain-related...

DOI: 10.1016/j.brainres.2024.149117 (opens in new tab) Full text (opens in new tab) Homer1a Mglur5 Depression therapy Neuropathic pain treatment +2

Effects of Different Anesthesia Applications on Mood, Depression, and Anxiety Levels in Burn Patients.

Journal of Burn Care & Research November 14, 2024 Ayça Tuba Dumanlı Özcan, Betül Akaycan, Serdar Süleyman Can et al. 4 citations

Adequate and effective pain management and prevention of depression are essential in patients with burns. This study aims to explore the effects of ketamine sedation in patients with burns in terms of mood disorders, depression, anxiety, and suicidality during postoperative follow-up in the intensive care unit. This study targeted subjects aged 18-65 years, in the ASA I-II class, with basic...

DOI: 10.1093/jbcr/irae105 (opens in new tab) Full text (opens in new tab) Depression Patients with burns Suicidal tendencies Mental health +4

Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression

Annual Review of Medicine November 11, 2024 Elizabeth Richardson, Riah Patterson, Samantha Meltzer-Brody et al. 33 citations

Depressive disorders present an enormous global public health burden. A notable treatment gap exists between the prevalence of depression and our ability to provide rapid-acting, effective treatment that achieves remission. Brexanolone and zuranolone, the first US Food and Drug Administration–approved drugs for postpartum depression, signify a critical advancement in addressing the unmet needs...

Ketamine attenuates kidney damage and depression-like behaviors in mice with cisplatin-induced acute kidney injury.

Translational Psychiatry November 9, 2024 Tianwen Huang, Yangyang He, Ruijuan Cheng et al. 5 citations

Acute kidney injury (AKI) is a serious condition characterized by decreased urine output, often accompanied by psychiatric symptoms like depression. However, there are limited pharmacological treatments available for AKI and its associated depressive symptoms. In this study, we investigated whether cisplatin-induced AKI in mice leads to depression-like behaviors and whether ketamine could...

DOI: 10.1038/s41398-024-03176-4 (opens in new tab) Full text (opens in new tab) Ketamine therapy Mental health treatment Nephrology research Psychopharmacology +1

The Algorithmic Agent Perspective and Computational Neuropsychiatry: From Etiology to Advanced Therapy in Major Depressive Disorder

Entropy November 6, 2024 Giulio Ruffini, Francesca Castaldo, Edmundo Lopez-Sola et al. 10 citations

Major Depressive Disorder (MDD) is a complex, heterogeneous condition affecting millions worldwide. Computational neuropsychiatry offers potential breakthroughs through the mechanistic modeling of this disorder. Using the Kolmogorov theory (KT) of consciousness, we developed a foundational model where algorithmic agents interact with the world to maximize an Objective Function evaluating...

DOI: 10.3390/e26110953 (opens in new tab) Major depressive disorder Neuropsychiatry Perspective graphical Etiology +3

S-ketamine alleviates depression-like behavior and hippocampal neuroplasticity in the offspring of mice that experience prenatal stress.

Scientific Reports November 6, 2024 Yan Zhang, Chu-Ke Wei, Ping Wang et al. 12 citations

Prenatal stress exerts long-term impact on neurodevelopment in the offspring, with consequences such as increasing the offspring's risk of depression in adolescence and early adulthood. S-ketamine can produce rapid and robust antidepressant effects, but it is not clear yet whether and how S-ketamine alleviates depression in prenatally stressed offspring. The current study incestigated the...